Axonics rises as prelim Q4 revenue beats expectations

Axonics

11/01/2023 15:28

** Shares of medical device company Axonics Inc  AXNX.O 
rise 10.7% to $61.81 - set for their biggest one-day pct jump in
8 months  
    ** Co expects Q4 2022 revenue between $85.6 mln and $86.0
mln, well above analysts' estimates of $76.87 mln - Refinitiv
    ** Strong revenue expectations for 2022 are driven by
increased year-over-year sales of co's urinary incontinence
therapies - ETON    
    ** AXNX expects full-year 2022 revenue to be around $273.6
mln, beating estimates of $263.54 mln
    ** Including session gains, AXNX rose nearly 9% in the past
12 months
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))